[{"id":"ee6449ac-5095-4fbb-b724-e910caded562","acronym":"","url":"https://clinicaltrials.gov/study/NCT03620058","created_at":"2021-01-18T17:47:19.570Z","updated_at":"2024-07-02T16:35:00.949Z","phase":"Phase 1","brief_title":"CART22 Alone or in Combination With huCART19 for ALL","source_id_and_acronym":"NCT03620058","lead_sponsor":"University of Pennsylvania","biomarkers":" CD22","pipe":" | ","alterations":" CD22 expression","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD22 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CART22 • huCART19"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 23","initiation":"Initiation: 09/27/2018","start_date":" 09/27/2018","primary_txt":" Primary completion: 01/01/2036","primary_completion_date":" 01/01/2036","study_txt":" Completion: 01/01/2036","study_completion_date":" 01/01/2036","last_update_posted":"2024-05-24"},{"id":"333c3c91-e311-42ae-a48a-8af632ca1e7b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02650414","created_at":"2021-01-18T12:54:06.464Z","updated_at":"2024-07-02T16:35:20.907Z","phase":"Phase 1","brief_title":"CD22 Redirected Autologous T Cells for ALL","source_id_and_acronym":"NCT02650414","lead_sponsor":"University of Pennsylvania","biomarkers":" CD22","pipe":" | ","alterations":" CD22 expression","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD22 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CART22"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 01/13/2016","start_date":" 01/13/2016","primary_txt":" Primary completion: 12/01/2037","primary_completion_date":" 12/01/2037","study_txt":" Completion: 12/01/2037","study_completion_date":" 12/01/2037","last_update_posted":"2024-02-05"},{"id":"70500982-fdb6-4f26-bc62-15198d012f0a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05674175","created_at":"2023-01-06T15:58:48.048Z","updated_at":"2024-07-02T16:35:25.792Z","phase":"Phase 1/2","brief_title":"Co-administration of CART22-65s and huCART19 for B-ALL","source_id_and_acronym":"NCT05674175","lead_sponsor":"Stephan Grupp MD PhD","biomarkers":" CD22","pipe":" | ","alterations":" CD19 expression • CD22 expression","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • CD22 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Kymriah (tisagenlecleucel-T) • CART22 • huCART19"],"overall_status":"Recruiting","enrollment":" Enrollment 93","initiation":"Initiation: 01/25/2023","start_date":" 01/25/2023","primary_txt":" Primary completion: 01/15/2027","primary_completion_date":" 01/15/2027","study_txt":" Completion: 01/15/2029","study_completion_date":" 01/15/2029","last_update_posted":"2023-12-19"}]